Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency

Clinical trial NCT04892693 · RECRUITING

Trial details

NCT number: NCT04892693
Sponsor: Seoul National University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer

Start date: 2021-05-25
Primary completion: 2027-05-31
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.